Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial

Keyphrases

• Randomized Placebo-controlled Trial 100%
• Anakinra 100%
• Colchicine-resistant Familial Mediterranean Fever 100%
• Placebo Groups 33%
• Placebo 25%
• Familial Mediterranean Fever 16%
• Randomized Controlled Trial 16%
• Quality of Life 16%
• Adverse Events 16%
• Visual Analog Scale 16%
• Number of Patients 16%
• Colchicine 16%
• Beneficial Effects 8%
• Effective Treatment 8%
• Mean Group 8%
• Treatment Duration 8%
• Interleukin 8%
• Severe Adverse Events 8%
• Safe Treatment 8%
• Efficacy Outcomes 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Placebo 100%
• Familial Mediterranean Fever 100%
• Colchicine 100%
• Anakinra 100%
• Adverse Event 25%
• Randomized Controlled Trial 16%
• Cytokine 8%